ADAPTED POSTERS

Titles of posters presented by ADAPTED researchers. For more information please contact the ADAPTED Project office at adapted@modus.ltd.

Development of a fast and versatile method for genome-wide association studies of longitudinal data

Presented by: Luca Kleineidam  (UKK)

Conference: Alzheimer's Association International Conference (AAIC) 2020

Proteomic, metabolomic, and transcriptomic examination of APOE transgenic mice

Presented by: Eric Mohler  (AbbVie)

Conference: Alzheimer's Association International Conference (AAIC) 2020

Identification of ApoE phenotypes in microglia and neurons derived from isogenic hiPS cells- a study of the IMI ADAPTED consortium

Presented by: Lamiaa Bahnassawy  (AbbVie)

Conference: Alzheimer's Association International Conference (AAIC) 2020

Multi-layer OMICS characterisation of APOE modulated isogenic hiPSCs elucidate cell type specific mechanisms modified by APOE - a study of the IMI ADAPTED consortium

Presented by: Janina Ried  (AbbVie)

Conference: Alzheimer's Association International Conference (AAIC) 2020

APOE and sex-stratified genome-wide meta-analyses of Alzheimer's disease

Presented by: Maria Saez (CAEBi)

Conference: Alzheimer's Association International Conference (AAIC) 2020

Candidates genes and pathways from ADAPTED Stage I integrative analysis

Presented by: Laura Madrid (CAEBi)

Conference: IMI 10th Anniversary Scientific Symposium

TMT-based comparison of ApoE ε4 and ε3 mouse brain samples – proteomics insights into the aetiology of Alzheimer’s disease

Presented by: Armel Nicolas (DCB) 

Conference: The Austrian Metabolomics and Proteomics Conference 2018 

Looking for therapeutic entry points for Alzheimer’s disease: lessons learned from agnostic trans-co-regulatory network analyses of APOE, TREM2, PLCG2 and ABI3 loci

Presented by: Agustín Ruiz (FACE) 

Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.  

Systematic APOE genotype-stratified analysis of human omics data - a study from the IMI ADAPTED project

Presented by: Margaretha Bakker (Abbvie)

Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.  

APOE-ε4 modulates levels of ω-3 and ω-6 fatty acids in Alzheimer’s disease dementia

Presented by: Holger Wagner (UKB),  Alfredo Ramirez (UKB).

 

Conference: The Alzheimer's Association International Conference (AAIC) 2018, Chicago, Illinios, USA.  

Modeling Alzheimer’s disease pathophysiology using isogenic human APOE iPSC-derived neural cells

Presented by: Lamiaa Bahnassawy (AbbVie) 

 

Conference: ISSCR Annual Meeting 2018, Melbourne, Australia 

Cerebrospinal fluid and plasma levels of Lysophosphatidic acids (LPAs) associate with cerebrospinal fluid Aβ-42 and P-tau

Presented by:  Shahzad Ahmad (EMC)

Conference: 2nd Meeting of Society of CSF analysis and clinical neurochemistry, Amsterdam, NL. 

Please reload